Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSun Yat-sen University

About this trial

To evaluate the locoregional control, survival rate, toxicity, and quality of life in patients with nasopharyngeal carcinoma treated with reduced prophylactic irradiation doses to the Low-Risk Clinical Target Volume (CTV).

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Radiation Therapy
  • Radiation Therapy

Treatment groups

700 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Sun Yat-sen University

Lead sponsor

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

Collaborator

Affiliated Hospital of Guangdong Medical University

Collaborator

The University of Hong Kong-Shenzhen Hospital

Collaborator

Dongguan People's Hospital

Collaborator

Affiliated Cancer Hospital of Shantou University Medical College

Collaborator